| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 02/06/2002 | EP0734386B1 Platelet activating factor antagonists: imidazopyridine indoles |
| 02/06/2002 | CN1334816A Triazolo (4,5-D) pyrimidine compounds |
| 02/06/2002 | CN1334728A Palladium-substd. bacteriochlorophll derivatives and use thereof |
| 02/06/2002 | CN1334266A Process for preparing natural chlorophyll zinc and its product |
| 02/05/2002 | US6344459 Treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis |
| 02/05/2002 | US6344451 Pyrrolobenzodiazepine carboxyamide vasopressin agonists |
| 02/05/2002 | US6344449 Headache and morphine dependence |
| 02/05/2002 | CA2078578C Medical use for tachykinin antagonists |
| 01/31/2002 | WO2002009196A1 Light harvesting arrays |
| 01/31/2002 | WO2002008230A1 Trans beta substituted chlorins and methods of making and using the same |
| 01/31/2002 | WO2002008229A1 1-(4-oxo-3,5-dihydro-4h-pyridazino[4,5-b]indole-1-carbonyl(piperazine) derivatives, their preparation and therapeutic application |
| 01/31/2002 | WO2002008228A2 Method for the manufacture of anagrelide |
| 01/31/2002 | WO2002008227A2 Bicyclic hydantoin derivatives and combinatorial libraries thereof |
| 01/31/2002 | WO2002008211A2 Benzothiazepines and their use as antihyperlipidemics |
| 01/31/2002 | WO2002008178A1 New combination of serotonin agonist (5ht2) and antagonist (5ht6)as pharmaceutical formulation |
| 01/31/2002 | WO2001081347A3 Diazabicyclic central nervous system active agents |
| 01/31/2002 | US20020013476 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 01/31/2002 | US20020013465 Reacting a benzamidine compound with a amide substituted pyrazole compound |
| 01/31/2002 | US20020013464 Reacting a benzamidine compound with a amide substituted pyrazole compound |
| 01/31/2002 | US20020013354 p38 map kinase inhibitors |
| 01/31/2002 | US20020013329 For therapy of pain, migraine, depression, anxiety, schizophrenia, Parkinson's disease, stroke, and in therapy of neuropathies including postherpetic neuralgia, central pain from spinal cord injury, and phantom limb pain |
| 01/31/2002 | US20020013328 For therapy of cancer or other proliferative diseases |
| 01/31/2002 | US20020013319 For therapy of tumor or restenosis |
| 01/31/2002 | US20020013309 Pharmaceutical compositions and methods for use |
| 01/31/2002 | US20020013299 For enhancing the chemotherapeutic treatment of tumor cells in a mammal with an antineoplastic alkylating agent, which causes cytotoxic lesions at the O6-position of guanine; O6-alkylguanine-DNA alkyltransferase (AGT) inactivator |
| 01/31/2002 | US20020013230 Contacting 3-amino-8-methoxy(1,2,4) triazolo(4,3-c)pyrimidine compounds with sodium or potassium methoxide in an alcohol solvent |
| 01/31/2002 | DE19881732C1 New phosphodiesterase inhibiting 2-phenyl-imidazotriazinone derivatives useful for treating e.g. cardiovascular, cerebrovascular and/or urogenital diseases |
| 01/31/2002 | DE10034801A1 Substituierte Amidoalkyl-uracile und ihre Verwendung Substituted amidoalkyl uracils and their use |
| 01/31/2002 | DE10034625A1 New aryl substituted thienyl-oxazolidinone derivatives useful as tumor necrosis factor-alpha inhibitors in treatment of e.g. atherosclerosis, arthritis, Crohn's disease, osteoporosis, transplant rejection and psoriasis |
| 01/31/2002 | DE10034624A1 New aryl substituted thienyl-oxazolidinone derivatives useful as tumor necrosis facto-alpha inhibitors in treatment of e.g. atherosclerosis, arthritis, Crohn's disease, osteoporosis, cardiac infraction and psoriasis |
| 01/31/2002 | CA2416654A1 Bicyclic hydantoin derivatives and combinatorial libraries thereof |
| 01/31/2002 | CA2411192A1 Combination of serotonin agonist (5ht2) and antagonist (5ht6)as a pharmaceutical formulation |
| 01/30/2002 | EP1176147A1 Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-ones and intermediates thereof |
| 01/30/2002 | EP1176146A1 Carbamoyl tetrahydropyridine derivatives |
| 01/30/2002 | EP1176145A1 Novel guanidino derivatives as inhibitors of cell adhesion |
| 01/30/2002 | EP1176142A1 Process for the preparation of pyrazoles |
| 01/30/2002 | EP1175470A1 Electronic device comprising organic compound having p-type semiconducting characteristics |
| 01/30/2002 | EP1175421A1 9H-PYRIMIDO[4,5-b]INDOLE DERIVATIVES: CRF1 SPECIFIC LIGANDS |
| 01/30/2002 | EP1175405A1 LACTAM INHIBITORS OF FXa AND METHOD |
| 01/30/2002 | EP1175398A1 Indoline derivatives as progesterone antagonists |
| 01/30/2002 | EP0670041B1 Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds |
| 01/30/2002 | CN1333766A Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compounds as factor xainhibitors |
| 01/30/2002 | CN1333758A Substituted bicyclic derivatives useful as anticancer agents |
| 01/30/2002 | CN1333757A Quinazoline derivatives as medicaments |
| 01/29/2002 | US6342601 Treating allograft rejection, rheumatoid arthritis |
| 01/29/2002 | US6342597 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid derivatives as chelating agents |
| 01/29/2002 | US6342503 Antidepressants, eating disorders |
| 01/29/2002 | US6342501 Viricides |
| 01/29/2002 | US6342379 Detection of transmembrane potentials by optical methods |
| 01/29/2002 | US6342244 Hydrophilic polymer covalently yet reversibly linked to a amine-containing ligand through a dithiobenzyl linkage; modification of various substrates, such as polypeptides, drugs and liposomes; upon cleavage of the linkage, the ligand |
| 01/29/2002 | CA2093322C Epoxy resins based on diaminobisimide compounds |
| 01/28/2002 | CA2354175A1 Process for the preparation of pyrazolo¬4,3-d|pyrimidin-7-one compounds and intermediates thereof |
| 01/24/2002 | WO2002006288A1 Tetrahydro-heterocycloazepinyl pyrimidine derivatives |
| 01/24/2002 | WO2002006287A2 Macrocyclic mri contrast agents |
| 01/24/2002 | WO2002006286A2 IMIDAZO[1,2-a]PYRAZINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS |
| 01/24/2002 | WO2002006285A1 Imidazolophthalazine derivatives as ligands for gabaa receptors |
| 01/24/2002 | WO2002006284A1 Indoloquinazolinones |
| 01/24/2002 | WO2002006247A1 Substituted amidoalkyl-uracils as parp inhibitors |
| 01/24/2002 | WO2001082780A3 Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents |
| 01/24/2002 | WO2001052892A3 Jak/stat pathway inhibitors and the uses thereof |
| 01/24/2002 | WO2001027107A3 Heterocyclic sodium/proton exchange inhibitors and method |
| 01/24/2002 | WO2001023387A3 CERTAIN ALKYLENE DIAMINE-SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES |
| 01/24/2002 | WO2001023357A3 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 01/24/2002 | WO2000071107A8 New pharmaceutical combinations for nos inhibitors |
| 01/24/2002 | US20020010339 Method for synthesis of halopyridyl-acyclopentane derivative and intermediate thereof |
| 01/24/2002 | US20020010335 Process and intermediates for growth hormone secretagogues |
| 01/24/2002 | US20020010330 Cyclization of an aminopyrrole compound |
| 01/24/2002 | US20020010175 Diazepinoindoles for the treatment of chronic obstructive pulmonary disease |
| 01/24/2002 | US20020010174 1,4-diazepine-2-one derivatives as neurokinin antagonist |
| 01/24/2002 | US20020010170 Pyrimido(1,6-b)pyridazine derivatives used as p38 inhibitors a mammalian protein kinase is involved in cell proliferation, cell death and response to extracellular stimuli |
| 01/24/2002 | US20020010159 Proton pump inhibitors |
| 01/24/2002 | US20020010098 Insecticides, nematodicides |
| 01/24/2002 | US20020009650 High electroconductivity |
| 01/24/2002 | US20020007520 Capable of generating intense colorings in varied shades |
| 01/24/2002 | CA2419626A1 Imidazo¬1,2-a|pyrazines for the treatment of neurological disorders |
| 01/24/2002 | CA2416036A1 Substituted amidoalkyl-uracils as parp inhibitors |
| 01/23/2002 | EP1174432A1 Phthalocyanine compounds, water-base ink compositions and colored products |
| 01/23/2002 | EP1174431A2 2-Phenyl-substituited Imidazotriazinones as Phoshodiesterase Inhibitors |
| 01/23/2002 | EP1173519A1 Novel carbopyronine fluorescence dyes |
| 01/23/2002 | EP1173440A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands |
| 01/23/2002 | EP1173438A1 Substituted imidazoles, their preparation and use |
| 01/23/2002 | EP1173423A1 Benzimidazolones and analogues and their use as progesterone receptor ligands |
| 01/23/2002 | EP1173223A2 Conjugates as therapies for cancers and prostate diseases |
| 01/23/2002 | EP1173222A2 Conjugate having a cleavable linkage for use in a liposome |
| 01/23/2002 | EP1173181A2 Compositions comprising phosphodiesterase inhibitors for the treatment of sexual disfunction |
| 01/23/2002 | EP0925368B1 Method for producing alcohols free of enantiomers |
| 01/23/2002 | EP0885225B1 Tetrahydropyrimidine derivatives |
| 01/23/2002 | EP0724586B1 Process for preparing n-(2,6-dichloro-3-methylphenyl)-5-7-dihalo[1,2,4]triazolo[1,5a]pyrimidine-2-sulfonamide by cyclization and halo-dehydroxylation |
| 01/23/2002 | EP0711292B1 Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity |
| 01/23/2002 | CN1332740A 5HT antagonists for antidepressant therapy |
| 01/22/2002 | US6340753 Cationic quaternary ammonium compounds dehydrohalogenation of compounds to form amines |
| 01/22/2002 | US6340745 Phthalocyanine and use of phthalocyanine as a marking agent |
| 01/22/2002 | US6340682 Diamide compound and drugs containing the same |
| 01/22/2002 | US6340681 Useful as analgesics in mammals |
| 01/22/2002 | CA2237971C Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
| 01/17/2002 | WO2002004465A1 Methods and kits for the detection of arginine compounds |
| 01/17/2002 | WO2002004454A1 Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species |
| 01/17/2002 | WO2002004453A2 PYRROLO[3,4-d]PYRIMIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS |
| 01/17/2002 | WO2002004447A1 Variolin derivatives as anti-cancer agents |
| 01/17/2002 | WO2002004442A2 Azabicyclic compounds as inhibitors of nicotinic cholinergic receptors |